X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (298) 298
index medicus (287) 287
ophthalmology (236) 236
female (231) 231
male (222) 222
aged (205) 205
middle aged (164) 164
glaucoma (143) 143
exfoliation syndrome - drug therapy (112) 112
open-angle glaucoma (110) 110
glaucoma, open-angle - drug therapy (95) 95
intraocular pressure (95) 95
aged, 80 and over (94) 94
exfoliation syndrome - physiopathology (87) 87
exfoliation syndrome - surgery (81) 81
intraocular pressure - drug effects (78) 78
prospective studies (75) 75
adult (72) 72
glaucoma, open-angle - physiopathology (65) 65
exfoliation syndrome (63) 63
glaucoma, open-angle - surgery (63) 63
exfoliation syndrome - complications (59) 59
treatment outcome (58) 58
antihypertensive agents - therapeutic use (56) 56
intraocular pressure - physiology (56) 56
tonometry, ocular (53) 53
surgery (51) 51
follow-up studies (49) 49
retrospective studies (48) 48
trabeculectomy (44) 44
intraocular-pressure (42) 42
antihypertensive agents - administration & dosage (38) 38
ocular hypertension (38) 38
ocular hypertension - drug therapy (35) 35
pseudoexfoliation syndrome (35) 35
exfoliation syndrome - diagnosis (34) 34
visual acuity (34) 34
trabeculectomy - methods (33) 33
medicine & public health (30) 30
care and treatment (29) 29
drug therapy, combination (29) 29
eyes (29) 29
abridged index medicus (28) 28
ophthalmic solutions (28) 28
phacoemulsification (28) 28
pseudoexfoliation (28) 28
timolol (28) 28
prostaglandins f, synthetic - therapeutic use (27) 27
risk factors (27) 27
cataract (26) 26
latanoprost (26) 26
visual acuity - physiology (26) 26
double-blind method (25) 25
eye diseases (25) 25
glaucoma, open-angle - complications (25) 25
antihypertensive agents - adverse effects (24) 24
exfoliation (24) 24
analysis (23) 23
exfoliation glaucoma (22) 22
prostaglandins f, synthetic - adverse effects (22) 22
cross-sectional studies (21) 21
eye (21) 21
lens implantation, intraocular (21) 21
safety (21) 21
cataract - complications (20) 20
efficacy (20) 20
follow-up (20) 20
glaucoma - drug therapy (20) 20
timolol - therapeutic use (20) 20
cloprostenol - analogs & derivatives (19) 19
genetic structures (19) 19
postoperative complications (19) 19
exfoliation syndrome - therapy (18) 18
glaucoma, open-angle - diagnosis (18) 18
laser therapy (18) 18
therapy (18) 18
timolol - administration & dosage (18) 18
drug combinations (17) 17
drug therapy (17) 17
exfoliation syndrome - etiology (17) 17
glaucoma, open-angle - therapy (17) 17
hypertension (17) 17
sense organs (17) 17
travoprost (17) 17
bimatoprost (16) 16
glaucoma, open-angle - etiology (16) 16
prevalence (16) 16
timolol - adverse effects (16) 16
trabecular meshwork - surgery (16) 16
administration, topical (15) 15
aqueous-humor (15) 15
exfoliation syndrome - metabolism (15) 15
ocular hypertension - physiopathology (15) 15
patients (15) 15
time factors (15) 15
adrenergic beta-antagonists - therapeutic use (14) 14
case-control studies (14) 14
exfoliative glaucoma (14) 14
gonioscopy (14) 14
ophthalmic drugs (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Ophthalmology, ISSN 0007-1161, 07/2013, Volume 97, Issue 7, pp. 857 - 861
Journal Article
Ophthalmology, ISSN 0161-6420, 2008, Volume 115, Issue 7, pp. 1117 - 1122.e1
Journal Article
Journal Article
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 05/2010, Volume 88, Issue 3, pp. 329 - 336
Purpose: The purpose of this study was to investigate the tolerability and intraocular pressure (IOP) reducing effect of the first preservative-free... 
latanoprost | Taflotan | Preservative-free tafluprost ophthalmic solution | Xalatan | Tolerability | IOP | Patient satisfaction | Quality of life | LATANOPROST | SIGNS | Taflotan (R) | Xalatan (R) latanoprost | PHARMACODYNAMICS | OCULAR SYMPTOMS | patient satisfaction | TAFLUPROST | preservative-free tafluprost ophthalmic solution | tolerability | OPHTHALMOLOGY | quality of life | RECEPTOR AGONIST | Hyperemia - metabolism | Intraocular Pressure - drug effects | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Male | Hyperemia - prevention & control | Conjunctival Diseases - metabolism | Ocular Hypertension - drug therapy | Patient Satisfaction | Prostaglandins F, Synthetic - administration & dosage | Aged, 80 and over | Tonometry, Ocular | Adult | Female | Surveys and Questionnaires | Conjunctival Diseases - chemically induced | HLA-DR Antigens - metabolism | Conjunctival Diseases - prevention & control | Preservatives, Pharmaceutical - adverse effects | Prostaglandins F - administration & dosage | Benzalkonium Compounds - adverse effects | Ophthalmoscopy | Benzalkonium Compounds - administration & dosage | Prostaglandins F, Synthetic - adverse effects | Blepharitis - metabolism | Glaucoma, Open-Angle - drug therapy | Blepharitis - prevention & control | Blepharitis - chemically induced | Exfoliation Syndrome - drug therapy | Mucin 5AC - metabolism | Quality of Life | Hyperemia - chemically induced | Aged | Gonioscopy | Preservatives, Pharmaceutical - administration & dosage | Administration, Topical | Glaucoma | Prostaglandins | Analysis | Pharmacy | Ophthalmic drugs | Mucins | Fluorescein | Ophthalmology | Universities and colleges | Drug therapy | Index Medicus
Journal Article